英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Nantissement查看　Nantissement　在百度字典中的解释百度英翻中〔查看〕
Nantissement查看　Nantissement　在Google字典中的解释Google英翻中〔查看〕
Nantissement查看　Nantissement　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • New Formulations of GLP-1s Demonstrate Positive Results . . .
    Of the over 38 million Americans who have diabetes, an estimated 90 to 95% have type 2 diabetes Glucagon-like peptide-1 (GLP-1) receptor agonists are a well-established treatment option for obesity and type 2 diabetes
  • Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist . . .
    Participants had type 2 diabetes treated only with diet and exercise, a glycated hemoglobin level of at least 7 0% but no more than 9 5%, and a body-mass index (the weight in kilograms divided by
  • New oral drug shows promise for type 2 diabetes and obesity . . .
    These are some of the most promising effects of a new potential drug treatment for people with type 2 diabetes and obesity, according to a new study published in the journal Cell by researchers
  • Orforglipron, an oral GLP-1, cut HbA1c, weight at 40 weeks . . .
    CHICAGO — Orforglipron, a novel nonpeptide, small molecule oral GLP-1, reduced HbA1c at 40 weeks for patients with type 2 diabetes, according to results of the phase 3 ACHIEVE-1 trial
  • New Diabetes Pill Targets Muscle and Burns Fat Without Side . . .
    For the millions living with type 2 diabetes or struggling with obesity, a pill that targets muscle, rather than the mind, could be more than just a new drug It could be a new way forward Reference: GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity, Cell (2025) DOI: 10 1016 j cell 2025 05 042
  • Orforglipron Q A | Eli Lilly and Company
    Orforglipron is an investigational, once-daily oral GLP-1 medication being studied for the treatment of type 2 diabetes and obesity It belongs to a class of medicines called GLP-1 receptor agonists and is designed to help lower blood sugar and support weight loss It comes in a pill form
  • New study reveals potential of first-in-class oral therapy to . . .
    Dr Ham said: “To date, ATR-258 has been a huge collaborative effort right across the drug discovery and development pipeline, from early stage discovery right through to clinical trials It’s really exciting to be a part of the team behind such a promising new option for people all over the world living with type 2 diabetes and obesity ”





中文字典-英文字典  2005-2009